Pagibaximab
Pagibaximab is a monoclonal antibody specifically designed for the prevention of Staphylococcus aureus infections in neonates. It is a type of biopharmaceutical that was developed by Biosynexus Incorporated and GlaxoSmithKline.
Mechanism of Action[edit | edit source]
Pagibaximab works by binding to the lipoteichoic acid (LTA) present in the cell wall of Staphylococcus aureus. This binding action inhibits the bacteria's ability to adhere to the host's cells, thereby preventing infection.
Clinical Trials[edit | edit source]
Pagibaximab has undergone several clinical trials to evaluate its safety and efficacy. In Phase II trials, it was found to be safe and well-tolerated in neonates at risk for Staphylococcus aureus infections. However, the drug did not meet the primary endpoint in Phase III trials, leading to the discontinuation of its development.
Potential Uses[edit | edit source]
Despite the discontinuation of its development, Pagibaximab has potential uses in the prevention of Staphylococcus aureus infections in other high-risk populations, such as patients undergoing hemodialysis or those with compromised immune systems.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD